SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-172343
Filing Date
2017-05-16
Accepted
2017-05-16 17:01:04
Documents
5
Period of Report
2017-06-30
Effectiveness Date
2017-05-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d372837ddef14a.htm DEF 14A 282238
2 GRAPHIC g372837g19s50.jpg GRAPHIC 19022
3 GRAPHIC g372837g58e52.jpg GRAPHIC 57630
4 GRAPHIC g372837snap0002.jpg GRAPHIC 1737
5 GRAPHIC g372837snap0003.jpg GRAPHIC 1756
  Complete submission text file 0001193125-17-172343.txt   394400
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37471 | Film No.: 17849389
SIC: 8731 Services-Commercial Physical & Biological Research